Cell Biotech Co. Ltd (049960) — Capital Reinvestment Ratio
Latest as of September 2025:
0.55x
Cell Biotech Co. Ltd (049960) has a Capital Reinvestment Ratio of 0.55x as of September 2025, meaning it reinvests 1% of its operating cash flow (₩4.15 Billion) in capital expenditures (₩2.29 Billion). See 049960 cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.55x
Capex / Operating Cash Flow
Operating Cash Flow
₩4.15 Billion
KRW
Capital Expenditures
₩2.29 Billion
KRW
Data as of
Sep 2025
Most recent filing
Cell Biotech Co. Ltd Capital Reinvestment Ratio (2011–2024)
This chart tracks Cell Biotech Co. Ltd's Capital Reinvestment Ratio across 14 annual periods.
Annual Capital Reinvestment Ratio for Cell Biotech Co. Ltd (2011–2024)
Year-by-year Capital Reinvestment Ratio for Cell Biotech Co. Ltd from 2011 to 2024. For live market cap and broader valuation context, see how much is Cell Biotech Co. Ltd worth.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.07x | ₩19.27 Billion | ₩1.28 Billion | ▼ -69.2% |
| 2023 | 0.22x | ₩7.82 Billion | ₩1.69 Billion | ▲ +3.4% |
| 2022 | 0.21x | ₩12.81 Billion | ₩2.67 Billion | ▲ +266.0% |
| 2021 | 0.06x | ₩14.89 Billion | ₩848.59 Million | ▼ -82.3% |
| 2020 | 0.32x | ₩9.56 Billion | ₩3.08 Billion | ▼ -65.2% |
| 2019 | 0.93x | ₩10.23 Billion | ₩9.47 Billion | ▲ +81.9% |
| 2018 | 0.51x | ₩13.98 Billion | ₩7.11 Billion | ▲ +114.0% |
| 2017 | 0.24x | ₩22.53 Billion | ₩5.36 Billion | ▲ +98.3% |
| 2016 | 0.12x | ₩17.99 Billion | ₩2.16 Billion | ▼ -35.4% |
| 2015 | 0.19x | ₩18.24 Billion | ₩3.38 Billion | ▲ +32.8% |
| 2014 | 0.14x | ₩9.91 Billion | ₩1.38 Billion | ▼ -80.1% |
| 2013 | 0.70x | ₩8.99 Billion | ₩6.31 Billion | ▲ +29.0% |
| 2012 | 0.54x | ₩6.17 Billion | ₩3.36 Billion | ▲ +411.4% |
| 2011 | 0.11x | ₩5.45 Billion | ₩580.85 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow